( Boston University Medical Center ) Glioblastma multiforme is one of the most lethal primary brain tumors, with median survival for these patients... ...http://health.infrosoft.com/index.php?page=news&op=readNews&id=44540&title=Researchers-find-promise-in-new-treatments-for-GBM
Custom Search NeoStem Establishes Melanoma Scientific Advisory Board to Support Anticipated Phase 3 Trial GlobeNewswire 2014-10-01 NEW... ...http://www.bizwireexpress.com/showstoryGNW.php?storyid=44524
In patients whose melanoma has progressed after treatment with ipilimumab, the monoclonal antibody nivolumab achieves superior response rates and a... ...http://www.medindia.net/news/monoclonal-antibody-nivolumab-shows-signs-of-superior-response-rate-in-advanced-melanoma-141912-1.htm
MADRID (Reuters) - A raft of new cancer drugs promise better, longer-lasting treatments with fewer adverse side effects -- but their high cost is a... ...http://in.reuters.com/article/2014/09/30/health-cancer-costs-idINKCN0HP1CC20140930
Researchers have developed two new anticancer peptide vaccines and two peptide inhibitors as part of a larger peptide immunotherapy effort. The... ...http://www.medindia.net/includes/whatsnew-tracking.asp?track=socialhits&secname=&ftitle=%20Researchers%20Develop%20New%20Anti-Cancer%20Peptide%20Vaccines%20and%20Inhibitors&furl=http://www.medindia.net/news/researchers-develop-new-anti-cancer-peptide-vaccines-and-inhibitors-141723-1.htm
CANCER HEALER CENTER is a cancer...